Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Bristol Myers Squibb presents new FPR agonists

Feb. 7, 2022

Klotho Therapeutics synthesizes novel compounds for hypertension

Feb. 7, 2022

Praxis Precision Medicines discovers potassium channel subfamily T member 1 inhibitors

Feb. 4, 2022

DDO-02005, a novel potent Kv1.5 potassium channel inhibitor with antiarrhythmic activity

Feb. 1, 2022

OR6A2 is a therapeutic target for atherosclerosis, researchers unveil

Feb. 1, 2022

Cereno advances CS-014 for cardiovascular diseases

Jan. 28, 2022

Therapeutic CAR T cells generated in the body reduce fibrosis in heart disease model in vivo

Jan. 26, 2022

Scripps Research Institute, ShangPharma Innovation patent Rev-erbA-alpha/beta agonists

Jan. 21, 2022

Researchers suggest ZEB2 targeting as an approach for atherosclerosis

Jan. 18, 2022

Targeting GNAO1 presents a new therapeutic strategy for heart failure

Jan. 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.